Lantheus Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lantheus Holdings, Inc. on March 17, 2023. The report discloses a significant executive leadership change within the company, specifically the appointment of a new President.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
- Executive Appointment: Paul Blanchfield was appointed as President of Lantheus Holdings, Inc. and its subsidiaries, effective March 20, 2023.
- Compensation Adjustment: Mr. Blanchfield's annual base salary was increased to $650,000.
- Equity Grants: Mr. Blanchfield received equity incentive awards valued at $1,006,390 (based on the April 15, 2023 closing price).
Outlook, Risks, and Management Commentary
The filing details the structure of the new equity awards granted to Mr. Blanchfield:
- Performance Stock Units (50%): Vesting is based on relative total shareholder return (rTSR) against the S&P 400 Health Care Index over a three-year period (January 1, 2023, to December 31, 2025), with a payout range of 0% to 200%.
- Restricted Stock Units (25%): Vesting occurs in three equal annual installments over three years.
- Stock Options (25%): Vesting occurs in three equal annual installments over three years, with share counts determined by Black-Scholes value.
The filing confirms there are no undisclosed arrangements regarding the appointment and no material conflicts of interest.
Investor Verification Checklist
- Verify the effective date of the President appointment (March 20, 2023).
- Confirm the total value of the equity grant ($1,006,390) and the specific valuation date used (April 15, 2023).
- Review the performance metrics for the rTSR component of the equity award.
- Check the attached press release (Exhibit 99.1) for additional context on the executive transition.